Abstract Details

Title Comparison of Clinical and Radiological Characteristics of Warfarin versus Novel Oral Anticoagulant Related Intracerebral Hemorrhages

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P1 - (-)

Poster/Presentation
Number 251

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Malgorzata Miller, MD (Corewell Health) PRESENTER	The institution of Dr. Miller has received research support from NIH StrokeNet VERIFY trial.
Nils Henninger, MD, PhD, FANA, FWSO (UMass Memorial Medical Center)	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.

��ɫ��